Liothyronine 20microgram tablets

Country: United Kingdom

Language: English

Source: MHRA (Medicines & Healthcare Products Regulatory Agency)

Active ingredient:

Liothyronine sodium

Available from:

DE Pharmaceuticals

ATC code:

H03AA02

INN (International Name):

Liothyronine sodium

Dosage:

20microgram

Pharmaceutical form:

Oral tablet

Administration route:

Oral

Class:

No Controlled Drug Status

Prescription type:

Valid as a prescribable product

Product summary:

BNF: 06020100

Patient Information leaflet

Each tablet contains
20 micrograms liothyronine
sodium.
Also contains lactose.
See leaflet for further
information.
To be taken by mouth.
Use as directed by your
doctor.
Keep out of the sight and
reach of children.
Protect from light.
Marketing Authorization Holder:
Mercury Pharma Group Ltd.,
Capital House, 85 King William
Street, London EC4N 7BL, UK
LIOTHYRONINE
SODIUM
20 MICROGRAMS
TABLETS
28 Tablets
20
MICROGRAMS
LL-119309-01
Peel here to read leaflet
PL10972/0033
POM
K
L
:
n
o
i
s
r
e
V
:
y
b
d
e
s
i
v
e
R
L
100201/LB/4, 100201/LF/4
M
CRF No.:
C
AMCo.CRF.260.2014
M
:
e
d
o
c
r
a
B
:
e
g
a
k
c
a
P
e
r
a
w
t
f
o
S
U
5021691 108528
M
Dimensions:
Pharma Code:
5
Key Line:
P
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE
BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor, pharmacist or
nurse.
-
This medicine has been prescribed for you only. Do not pass it on to
others.
It may harm them, even if their signs of illness are the same as
yours.
-
If you get any side effects, talk to your doctor, pharmacist or nurse.
This
includes any possible side effects not listed in this leaflet. See
section 4.
suitable oral syringe to withdraw
the amount of liquid corresponding
to the dose prescribed (5mL for a
5mcg dose; 10 mL for a 10mcg
dose) and squirt the liquid directly
into your mouth by gently pressing
the plunger
• Any remaining liquid should be
discarded.
ADULTS:
The dose will depend upon your
condition, ranging from 10 micrograms
to 60 micrograms daily in divided doses.
CHILDREN AND ELDERLY:
The dose may be started at
5 micrograms a day.
Please note that your doctor will
monitor your thyroid function regularly
to make sure that you are given the
right dose for your condition.
The score line is not intended for
breaking the tablet.
IF YOU TAKE MORE LIOTHYRONINE
SODIUM TABLETS THAN YOU SHOULD:
This may cause agitation, confusion,
headache, sweating and a rapid pulse.
If you take too many tabl

Summary of Product characteristics

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Tertroxin Tablets 20mcg
Liothyronine Sodium BP 20micrograms Tablets
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 20mcg liothyronine sodium BP.
Excipient(s) with known effect: Lactose
For the full list of excipients, see section 6.1.
_ _
3
PHARMACEUTICAL FORM
Tablets
The score line is not intended for breaking the tablet. See section
4.2.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Liothyronine sodium tablets are qualitatively similar in biological
action to thyroxine
but the effect develops in a few hours and lasts for 24 to 48 hours
after stopping the
treatment.
Used for the treatment of coma of myxedema, the management of severe
chronic
thyroid deficiency and hypothyroid states occurring in the treatment
of thyrotoxicosis.
Liothyronine sodium can be used also in the treatment of
thyrotoxicosis as an adjunct
to carbimazole to prevent sub-clinical hypothyroidism developing
during treatment.
Liothyronine sodium may be preferred for treating severe and acute
hypothyroid
states because of its rapid and more potent effect, but thyroxine
sodium is normally
the drug of choice for routine replacement therapy.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
Adults: Starting dose of 10 or 20 micrograms every 8 hours, increasing
after one
week, if necessary, to the usual recommended daily dose of 60
micrograms in two or
three divided doses.
Myxedema Coma: 60 micrograms given by stomach tube, then 20 micrograms
every
8 hours. It is more usual to start treatment with intravenous
liothyronine.
Adjunct to carbimazole treatment of thyrotoxicosis: 20 micrograms
every 8 hours.
Elderly and Children Patients: 5 micrograms daily.
Method of Administration: Oral
•
For
doses
lower
than
20
micrograms,
the
tablet
should
be
allowed
to
dissolve/disperse in 20 mL of water for 10 minutes, in a small
measuring cup.
•
The
patient
should
gently
swirl
the
solution
occasionally
to
aid
the
dissolution/dispersion. The patient should then swirl the so